Immunocytokines, such as interleukin-1 (IL-1), have been shown to be i
nvolved in the activation and/or induction of a variety of transcripti
on factors which may modulate the expression of genes possessing DNA b
inding sites on which these transcription factors act. The promoter DN
A sequence of the mu opioid receptor gene contains IL-1 response eleme
nts such as NF-IL6, and, therefore, the receptor gene may be responsiv
e to IL-1. To investigate the effect of IL-1 on the opioid receptor ge
ne, the in vitro expression of mu opioid receptor mRNA in neural micro
vascular endothelial cells (NMVEC) was determined before and after IL-
1 treatment. PCR analysis revealed that there was virtually no mu opio
id receptor expression at basal levels and no increase after either IL
-1 alpha or IL-1 beta treatment. However, simultaneous treatment with
both IL-1 alpha and IL-1 beta increased mu opioid receptor expression.
This upregulation of mu opioid receptor expression provides direct ev
idence of a relationship between opioid and cytokine actions, and sugg
ests that opioid-dependent pathways may be modulated in the disease st
ate. (C) 1998 Elsevier Science B.V.